| 6.10 Data as of Apr 30 |  0.00 / 0.00%Today’s Change | 2.00 Today|||52-Week Range 7.10 | +205.00% Year-to-Date |
| Previous close | 6.10 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 0 |
| Average volume (3 months) | 4,542 |
| Market cap | $1.3B |
| Dividend yield | -- |
| Earnings growth (last year) | -619.27% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +202.20% |
| Revenue growth (last year) | -3.83% |
| P/E ratio | -- |
| Price/Sales | 5.21 |
| Price/Book | 2.18 |
| No competitors data available. |
| Next reporting date | July 18, 2013 |
| EPS forecast (this quarter) | -$0.01 |
| Annual revenue (last year) | $286.3M |
| Annual profit (last year) | -$15.0M |
| Net profit margin | -5.25% |
Sector Health Technology |
Industry Biotechnology |
President & Chief Executive Officer Geoffrey C. McDonough, MD |
Chief Operating Officer Alan Raffensperger, PhD, MBA |
Corporate headquarters Stockholm, -- |
.
